Immunological assays remain of crucial importance both for driving the diagnosis (as in the case of dihydrorhodamine (DHR) test for CGD or measure of WASP expression in WAS) and for confirming the causative role of variants of uncertain significance (VUS) detected by NGS. This evidence concerns the gene WAS and chronic granulomatous disease.